AffPaysInc.i
Merge
Accueil
Racine
Merge
Exploration
Accueil
Racine
Accueil
Racine

Serveur d'exploration Tocilizumab - Merge (Accueil)

Index « AffPaysInc.i » - entrée « Osaka University »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Osaka Red Cross Hospital < Osaka University < Osaka University Graduate School of Medicine  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 5.
Ident.Authors (with country if any)Title
002007 (2015) Toshio TanakaIL-6 blockade therapy for inflammatory diseases: current perspectives and future directions.
004126 (2008) Kazuyuki Yoshizaki[Pathogenic analysis of chronic inflammatory disease based on the clinical results by IL-6 blocking therapy].
004240 (2007) Norihiro Nishimoto[Humanized anti-human IL-6 receptor antibody, tocilizumab].
004308 (2006) Norihiro Nishimoto[Anti-interleukin-6 receptor antibody therapy--from bedside to bench].
004338 (2005) Norihiro Nishimoto[Anti-IL-6 receptor antibody].

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Merge

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/AffPaysInc.i -k "Osaka University" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/AffPaysInc.i  \
                -Sk "Osaka University" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Merge
   |type=    indexItem
   |index=    AffPaysInc.i
   |clé=    Osaka University
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021